Lisa Bodell: Change Is a Choice
In this article, Lisa Bodell challenges the way we typically think about change. Rather than viewing it as a dramatic, all-or-nothing leap, she reframes change…
Thought Leader: Lisa Bodell
By Newt Gingrich (original source Fox News)
“Over the past three decades, I have consistently spoken about the enormous potential of biomedical breakthroughs that could solve many of our pressing public challenges. Because of this potential, I have advocated for increased public funding of basic scientific research and reforms at the Food and Drug Administration to speed up the process by which new treatments are available to patients.
One of the most exciting areas of biomedical science today is in genetic medicine, where we are just now seeing the public investment into sequencing the human genome bear fruit in the form of treatments to help patients overcome hereditary disorders.”
Click here to read more
Lisa Bodell: Change Is a Choice
In this article, Lisa Bodell challenges the way we typically think about change. Rather than viewing it as a dramatic, all-or-nothing leap, she reframes change…
Thought Leader: Lisa Bodell
Sara Fischer on Meta’s AI Infrastructure Push
In an article by Sara Fischer, Meta CEO Mark Zuckerberg outlines the company’s launch of Meta Compute, a new top-level initiative focused on scaling AI…
Thought Leader: Sara Fischer
Ian Bremmer: What’s Next for Venezuela
After the US captures Nicolás Maduro, is Venezuela headed for stability, or chaos? Ian Bremmer talks to Senator Ruben Gallego and Frank Fukuyama about what…
Thought Leader: Ian Bremmer